What is the current stock price of PetVivo Holdings, Inc. (PETV)?

As of the latest market data, PetVivo Holdings, Inc. (PETV) is trading at $0.73. The stock has seen a gain of 4.71% today.

Does PetVivo Holdings, Inc. (PETV) pay a dividend?

Based on current data, PetVivo Holdings, Inc. does not have a confirmed active dividend policy.

What is the market cap of PetVivo Holdings, Inc.?

The current market capitalization of PetVivo Holdings, Inc. (PETV) is approximately unavailable.

PETV

PetVivo Holdings, Inc.·Healthcare

0.73

4.714%(+0.03)

Market Closed

0.76

3.683%(+0.03)

After Hours

Last Updated: — ET

52W L: $0.4552W H: $1.69

PETV NEWS

defenseworld.net

Mar 11

PetVivo (NASDAQ:PETV) Trading Down 11% – Should You Sell?

PetVivo Holdings, Inc. (NASDAQ: PETV - Get Free Report)'s share price dropped 11% during trading on Tuesday. The stock traded as low as $0.6873 and last traded at $0.7050. Approximately 16,865 shares were traded during trading, an increase of 19% from the average daily volume of 14,208 shares. The stock had previously closed at $0.7920.

seekingalpha.com

Feb 17

PetVivo Holdings, Inc. (PETV) Q3 2026 Earnings Call Transcript

globenewswire.com

Feb 17

PetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026

MINNEAPOLIS, MN, US, Feb. 17, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTC ID: PETVW), and its wholly owned subsidiaries PetVivo Animal Health and PetVivo AI, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported financial and operational results for the third quarter and first nine months of its fiscal year 2026 ended December 31, 2025.

globenewswire.com

Feb 10

PetVivo Issues Correction and Replacement Press Release; Sets Fiscal Third Quarter 2026 Conference Call for Tuesday, February 17, 2026 at 5:00 p.m. ET

MINNEAPOLIS, MN, US, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., in collaboration with its wholly-owned subsidiary PetVivo Animal Health (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, today announced that it is retracting and replacing its previously issued press release dated February 9, 2026 regarding the Company's fiscal third quarter 2026 conference call.

globenewswire.com

Feb 9

PetVivo Sets Fiscal Third Quarter 2026 Conference Call for Monday, February 16, 2026 at 5:00 p.m. ET

MINNEAPOLIS, MN, US, Feb. 09, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Monday, February 16, 2026 at 5:00 p.m. Eastern time to discuss results for the fiscal third quarter ended December 31, 2025. The financial results will be issued in a press release prior to the call.

Company Profile

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2014-09-08

Beta

1.20

Websitewww.petvivo.com↗